Articles with public access mandates - Mechthild KrauseLearn more
Not available anywhere: 34
EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms
M Baumann, M Krause, E Dikomey, K Dittmann, W Dörr, U Kasten-Pisula, ...
Radiotherapy and Oncology 83 (3), 238-248, 2007
Mandates: German Research Foundation
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation
A Yaromina, M Krause, H Thames, A Rosner, M Krause, F Hessel, ...
Radiotherapy and oncology 83 (3), 304-310, 2007
Mandates: German Research Foundation
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary …
A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ...
Radiotherapy and Oncology 121 (3), 364-373, 2016
Mandates: Federal Ministry of Education and Research, Germany
Cancer stem cells at the crossroads of current cancer therapy failures—radiation oncology perspective
U Koch, M Krause, M Baumann
Seminars in cancer biology 20 (2), 116-124, 2010
Mandates: German Research Foundation
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in …
A Yaromina, D Zips, HD Thames, W Eicheler, M Krause, A Rosner, ...
Radiotherapy and oncology 81 (2), 122-129, 2006
Mandates: German Research Foundation
Cancer stem cells and radiotherapy
M Baumann, M Krause, H Thames, K Trott, D Zips
International journal of radiation biology 85 (5), 391-402, 2009
Mandates: German Research Foundation
Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining
A Menegakis, A Yaromina, W Eicheler, AR Dörfler, B Beuthien-Baumann, ...
International journal of radiation biology 85 (11), 1032-1041, 2009
Mandates: German Research Foundation
Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy
M Krause, D Zips, HD Thames, J Kummermehr, M Baumann
Radiotherapy and oncology 80 (2), 112-122, 2006
Mandates: German Research Foundation
A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection
J Hess, K Unger, C Maihoefer, L Schüttrumpf, L Wintergerst, T Heider, ...
Clinical Cancer Research 25 (5), 1505-1516, 2019
Mandates: Helmholtz Association, Federal Ministry of Education and Research, Germany
In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio
C Gani, C Coackley, R Kumareswaran, C Schütze, M Krause, G Zafarana, ...
Radiotherapy and Oncology 116 (3), 486-494, 2015
Mandates: Canadian Cancer Society, Prostate Cancer Canada
The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity
D Digomann, I Kurth, A Tyutyunnykova, O Chen, S Löck, I Gorodetska, ...
Clinical Cancer Research 25 (10), 3152-3163, 2019
Mandates: Austrian Science Fund, German Research Foundation, UK Engineering and …
EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?
M Krause, J Prager, X Zhou, A Yaromina, A Dörfler, W Eicheler, ...
Radiotherapy and oncology 83 (3), 316-325, 2007
Mandates: German Research Foundation
Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest
M Kriegs, K Gurtner, Y Can, I Brammer, T Rieckmann, R Oertel, ...
Radiotherapy and Oncology 115 (1), 120-127, 2015
Mandates: German Research Foundation
CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer
S Leger, A Zwanenburg, K Pilz, S Zschaeck, K Zöphel, J Kotzerke, ...
Radiotherapy and Oncology 130, 10-17, 2019
Mandates: Federal Ministry of Education and Research, Germany
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material
A Menegakis, C von Neubeck, A Yaromina, H Thames, S Hering, ...
Radiotherapy and Oncology 116 (3), 473-479, 2015
Mandates: German Research Foundation
Precise image-guided irradiation of small animals: a flexible non-profit platform
F Tillner, P Thute, S Löck, A Dietrich, A Fursov, R Haase, M Lukas, ...
Physics in Medicine & Biology 61 (8), 3084, 2016
Mandates: Helmholtz Association
Molecular imaging of σ1 receptors in vivo: current status and perspectives
P Brust, W Deuther-Conrad, K Lehmkuhl, H Jia, B Wünsch
Current medicinal chemistry 21 (1), 35-69, 2014
Mandates: German Research Foundation
Comparison study of in vivo dose response to laser-driven versus conventional electron beam
M Oppelt, M Baumann, R Bergmann, E Beyreuther, K Brüchner, ...
Radiation and environmental biophysics 54, 155-166, 2015
Mandates: German Research Foundation
Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors
M Krause, K Gurtner, Y Deuse, M Baumann
International Journal of Radiation Biology 85 (11), 943-954, 2009
Mandates: German Research Foundation
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: a multicenter DKTK/ROG analysis
M Niyazi, S Adeberg, D Kaul, AL Boulesteix, N Bougatf, DF Fleischmann, ...
Radiotherapy and Oncology 127 (1), 121-127, 2018
Mandates: Federal Ministry of Education and Research, Germany
Publication and funding information is determined automatically by a computer program
